脉管畸形
- 网络Malformations;Vascular malformation
![脉管畸形](../cache/1193300.jpg)
-
结果:随访期间,肿瘤治愈率为67.5%(79/117),对影响儿童颌面部脉管畸形手术疗效的单因素分析结果显示:肿瘤大小、瘤体包膜是否完整与手术疗效相关(P0.05)。
Results : The tumor cure rate was 67.5 % ( 79 / 117 ) . Logistic regression analysis showed that the prognosis of the vascular malformation of oral and maxillofacial region in infancy and childhood was related to the tumor size and completeness of peplos .
-
血管瘤和脉管畸形新分类诊断和治疗
Dignosis and therapy on hemangiomas and vascular malformation in view of the new classification
-
软组织脉管畸形的MRI诊断
MRI Diagnosis of Soft Tissue Vascular Malformations
-
目的评价平阳霉素(PYM)与地塞米松联合应用病变内注射治疗口腔颌面部各种脉管畸形的疗效。
Objective To evaluate the effect of combined intralesional injection of pingyangmycin ( PYM ) and dexamethasone in the treatment of maxillofacial vascular malformations .
-
AgNOR和肥大细胞计数,血管瘤明显高于脉管畸形组,表明血管瘤和脉管畸形是性质不同的两种病变。
The counts of AgNOR and mast cells in hemangiomas were significantly higher than those in vascular malformations . The results indicated that hemangiomas and vascular malformations were different lesions in nature .
-
结论PYM和地塞米松联合瘤内注射是治疗口腔颌面部脉管畸形一种较佳的治疗方法,疗效高,安全可靠,但应对脉管畸形病变进行正确分类,掌握其适应证。
Conclusion This method may be a safe , simple and effective therapy for vascular malformations of the maxillofacial region . It is critical to correctly identify the type lesion before the treatment .
-
方法采用PYM和地塞米松联合病变内注射治疗口腔颌面部脉管畸形患者200例(225个瘤体)5~7d注射一次,3~5次为一个疗程。
Methods Two hundreds patients with maxillofacial vascular malformations were treated with combined intralesional injections of PYM and dexamethasone . The injection was administered once every 5 to 7 days for 3 to 5 weeks .
-
纵隔混合型脉管畸形1例报告
One Case : Mixed Vascular Malformation of the Mediastinum
-
方法采用多次小剂量90锶、90镱对96例患儿颌面部血管瘤、脉管畸形进行敷贴治疗。
Methods The application therapy was used in 96 patients for hemangioma of the face .
-
平阳霉素地塞米松联合治疗口腔颌面部脉管畸形
The effect of combined injection with PYM and dexamethasone in treatment of vascular malformation of maxillofacial region
-
脉管畸形的激光治疗
Laser treatment of vascular malformations
-
合并呼吸道梗阻的血管瘤和脉管畸形32例治疗分析
Treatment of hemangiomas and vascular malformations associated with airway obstruction : An assessment of 32 consecutive cases
-
目的观察综合治疗体表血管瘤及脉管畸形的临床疗效。
Objective To observe the clinical therapeutic efficacy of comprehensive treatment on body surface hemangioma and vascular malformations .
-
目的观察应用90锶、90镱敷贴器治疗婴幼儿颌面部血管瘤、脉管畸形的疗效。
Objective To study the effects of90 Sr90 Y application therapy for hemangioma and vascular malformation in oral and maxillulae region .
-
结果:血管瘤内皮细胞增生为Ⅱ、Ⅲ级,而脉管畸形组内皮细胞增生为O或I级。
The results showed that the endothelial proliferations in vascular malformations were grade o or grade ⅰ, while those in hemangiomas were grade ⅱ or grade ⅲ .
-
平阳霉素治疗血管瘤与脉管畸形严重不良反应的防治不同药物预防全麻拔管期间心血管反应的观察
Clinical analysis of adverse effects of pingyangmycin in treatment of hemangiomas and vascular malformations Comparison of the Effects of different drugs on attenuation of cardiovascular responses to tracheal extubation
-
结论:瘤体大小及包膜是否完整是影响手术疗效的主要因素,术前准确、全面地评估肿瘤范围,包膜是否完整、正确把握手术适应症,可以提高脉管畸形治愈率。
Conclusion : The completeness of peplos and size of tumor were the crucial factor in therapeutic efficacy . The general assessment of the peplos and size , preoperative vascular malformation may increase the recovery rate .